|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Xen and the art of virtualization显示文摘 | Paul Barham Boris Dragovic Keir Fraser Steven Hand Tim Harris Alex Ho Rolf Neugebauer Ian Pratt Andrew Warfield | 2003 | ACM SIGOPS Operating Systems Review2003，，5： | 6 |
| 2 | CHANGES IN CHANNEL PATTERN OF RIVER GANGA BETWEEN MUSTAFABAD AND RAJMAHAL, GANGETIC PLAINS SINCE 18TH CENTURY显示文摘Morphological analyses require quantitative description of river course by providing its equation. Such an equation is not possible as the river plan-form contains loops that cannot be described by it. To circumvent this difficulty a system of parametric equations is devised for describing the river plan-form.The system of equations was used to obtain morphological attributes like sinuosity and curvature. Using the plan-form data for the River Ganga for years 1780, 1828, 1853, 1935 and 1978 the parametric equations were setup for these years. The plan-forms were to study the changes in channel pattern,sinuosities and mode of movement of meander loops with time in the last two centuries and in the downstream direction in the Ganga River between Mustafabad and Rajmahal over about 900 km long course. | Prabhata K. SWAMEE Barham PARKASH Jayaprakash V THOMAS Satvindar SINGH | 2003 | International Journal of Sediment Research2003，18，3： | 3 |
| 3 | Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage显示文摘Anabolic steroid abuse is common among athletes and is associated with a number of medical complications. We describe a case of a 27-year-old male bodybuilder with multiple hepatic adenomas induced by anabolic steroids. He initially presented with tumor hemorrhage and was treated with left lateral hepatic segmentectomy. Regression of the remaining tumors was observed with cessation of steroid use. However, 3 years and a half after his initial hepatic segmentectomy, he presented with recurrent tumor enlargement and intraperitoneal hemorrhage in the setting of steroid abuse relapse. Given his limited hepatic reserve, he was conservatively managed with embolization of the right accessory hepatic artery. This is the first reported case of hepatic adenoma re- growth with recidivistic steroid abuse, complicated by life-threatening hemorrhage. While athletes and bodybuilders are often aware of the legal and social ramifications of steroid abuse, they should continue to be counseled about its serious medical risks. | Nicole M Martin Barham K Abu Dayyeh Raymond T Chung | 2008 | World Journal of Gastroenterology2008，14，28： | 3 |
| 4 | Percutaneous transluminal angioplasty balloons for endoscopic ultrasound-guided pancreatic duct interventions显示文摘BACKGROUND Endoscopic ultrasound(EUS)-guided main pancreatic duct(PD)access may be used when conventional endoscopic retrograde cholangiopancreatography(ERCP)techniques fail.The use of a percutaneous transluminal angioplasty balloon(PTAB),originally developed for vascular interventions,can be used to facilitate transmural(e.g.,transgastric)PD access and to dilate high-grade pancreatic strictures.AIM To describe the technique,efficacy,and safety of PTABs for EUS-guided PD interventions.METHODS Patients who underwent EUS with use of a PTAB from March 2011 to August 2021 were retrospectively identified from a tertiary care medical center supply database.PTABs included 3-4 French angioplasty catheters with 3-4 mm balloons designed to use over a 0.018-inch guidewire.The primary outcome was technical success.Secondary outcomes included incidence of adverse events(AEs)and need for early reintervention.RESULTS A total of 23 patients were identified(48%female,mean age 55.8 years).Chronic pancreatitis was the underlying etiology in 13(56.5%)patients,surgically altered anatomy(SAA)with stricture in 7(30.4%),and SAA with post-operative leak in 3(13.0%).Technical success was achieved in 20(87%)cases.Overall AE rate was 26%(n=6).All AEs were mild and included 1 pancreatic duct leak,2 cases of post-procedure pancreatitis,and 3 admissions for post-procedural pain.No patients required early re-intervention.CONCLUSION EUS-guided use of PTABs for PD access and/or stricture management is feasible with an acceptable safety profile and can be considered in patients when conventional ERCP cannulation fails. | Jad P AbiMansour Barham K Abu Dayyeh Michael J Levy Andrew C Storm John A Martin Bret T Petersen Ryan J Law Mark D Topazian Vinay Chandrasekhara | 2022 | World Journal of Gastrointestinal Endoscopy2022，14，8： | 2 |
| 5 | End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients显示文摘AIM To determine if end-stage renal disease (ESRD) is a risk factor for post endoscopic retrograde cholangio-pancreatography (ERCP) adverse events (AEs). METHODS We performed a retrospective cohort study using the Nationwide Inpatient Sample (NIS) 2011-2013. We identified adult patients who underwent ERCP using the International Classification of Diseases 9^(th) Revision (ICD-9-CM). Included patients were divided into three groups: ESRD, chronic kidney disease (CKD), and control. The primary outcome was post-ERCP AEs including pancreatitis, bleeding, and perforation determined based on specific ICD-9-CM codes. Secondary outcomes were length of hospital stay, in-hospital mortality, and admission cost. AEs and mortality were compared using multivariate logistic regression analysis.RESULTS There were 492175 discharges that underwent ERCP during the 3 years. The ESRD and CKD groups contained 7347 and 39403 hospitalizations respectively, whereas the control group had 445424 hospitalizations. Post-ERCP pancreatitis (PEP) was significantly higher in the ESRD group (8.3%) compared to the control group (4.6%) with adjusted odd ratio (aOR) = 1.7 (95% CI: 1.4-2.1, ~aP < 0.001). ESRD was associated with significantly higher ERCP-related bleeding (5.1%) compared to the control group 1.5% (aOR = 1.86, 95%CI: 1.4-2.4, ~aP < 0.001). ESRD had increased hospital mortality 7.1% vs 1.15% in the control OR = 6.6 (95%CI: 5.3-8.2, ~aP < 0.001), longer hospital stay with adjusted mean difference (aMD) = 5.9 d (95% CI: 5.0-6.7 d, ~aP < 0.001) and higher hospitalization charges aMD = $+82064 (95%CI: $68221-$95906, ~aP < 0.001). CONCLUSION ESRD is a risk factor for post-ERCP AEs and is associated with higher hospital mortality. Careful selection and close monitoring is warranted to improve outcomes. | Tarek Sawas Fateh Bazerbachi Samir Haffar Won K Cho Michael J Levy John A Martin Bret T Petersen Mark D Topazian Vinay Chandrasekhara Barham K Abu Dayyeh | 2018 | World Journal of Gastroenterology2018，24，41： | 2 |
| 6 | 内镜下胰管支架置入术用于缓解胰腺癌患者的疼痛:系统综述与meta分析显示文摘背景:腹痛是一种致人衰弱的症状,大约80%的胰腺癌患者都会出现腹痛。胰管减压虽然未被广泛采纳,但有报道该方法能缓解腹痛症状。本研究旨在评估内镜下胰管减压对于缓解胰腺癌患者餐后梗阻型腹痛的作用、效果及安全性。方法:该系统综述的文献检索时间截至2020年10月7日。由两位研究者独立地筛选文献、提取数据,并对文献质量进行评估。结果:12篇文献共计192例有腹痛症状且尝试胰管减压的胰腺癌患者纳入研究。其中,167例患者成功完成胰管减压(平均年龄62.5岁,58.7%为男性)。159(95.2%)例患者采用塑料支架。所有被纳入的研究均报道了胰管支架置入术后患者疼痛部分或完全缓解,缓解率为93%(95%CI:79%-100%)。平均的疼痛缓解期为94˘16天。内镜逆行性胰胆管造影(ERCP)相关的不良反应包括括约肌切开术后出血(1.8%)、ERCP后胰腺炎(0.6%)和胰管出血(0.6%)。2例行内镜超声引导的胰管减压患者未报道任何不良反应。在成功置入支架的167例患者中,支架移位和支架阻塞的发生率分别为3.6%和3.0%。未报道不良反应相关的死亡病例。文献质量评估提示,绝大部分文献质量较低或难以评价。结论:初步分析结果表明,对于部分经选择的胰腺癌病例,内镜下胰管引流可能是缓解梗阻型疼痛一种安全有效的方法。但该侵入性方法的作用尚需随机对照研究来进一步明确。 | Pradeep K.Siddappa Fadi Hawa Larry J.Prokop MHassan Murad Barham K.Abu Dayyeh Vinay Chandrasekhara Mark D.Topazian Fateh Bazerbachi | 2021 | Gastroenterology Report2021，9，2： | 2 |
| 7 | Xen and the art of virtualization显示文摘 | Paul Barham Boris Dragovic Keir Fraser Steven Hand Tim Harris Alex Ho Rolf Neugebauer Ian Pratt Andrew Warfield | 2003 | ACM SIGOPS Operating Systems Review2003，，5： | 2 |
| 8 | ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies显示文摘 | Barham K. Abu Dayyeh Nitin Kumar Steven A. Edmundowicz Sreenivasa Jonnalagadda Michael Larsen Shelby Sullivan Christopher C. Thompson Subhas Banerjee | 2015 | Gastrointestinal Endoscopy2015，，3： | 2 |
| 9 | Endoscopic bariatric therapies显示文摘 | Barham K. Abu Dayyeh Steven A. Edmundowicz Sreenivasa Jonnalagadda Nitin Kumar Michael Larsen Shelby Sullivan Christopher C. Thompson Subhas Banerjee | 2015 | Gastrointestinal Endoscopy2015，，5： | 2 |
| 10 | Xen and the Art of Virtualizotion显示文摘 | Paul Barham BorisBoris Dragovic | 2003 | In:Proceeddings of the 19th ACM symposium on Operating systems principles2003，，： | 1 |
| 11 | Genetic regulation of embl)'ological limb devel- opment with relation to congenital limb deformity in humans显示文摘 | Barham G Clarke NM | 2008 | J Child Orthop2008，2，1： | 1 |
| 12 | Crystallization and morphology of a bacterial thermoplastic:poly-3-hydroxybutyrate显示文摘 | Barham P J Keller A Otun E L | 1984 | Journal of Materials Science1984，，19： | 1 |
| 13 | Universities and agricultur- al biotechnology patent production显示文摘 | Foltz J Kim K Barham B | 2008 | Research Policy2008，16，1： | 1 |
| 14 | The inheritance of a bitter principle in cu- cumbers显示文摘 | Barham W S | 1953 | Proc Amer Soc Hort Sci1953，62，： | 1 |
| 15 | Schwertmannite : a unique mineral, contains areplaceable ligand,transforms to jarosites, hematites,and/orbasic iron sulfate 显示文摘 | Barham R J | 1997 | Journal of Materials Research1997，12，10： | 1 |
| 16 | Breast masses:removalof all US evidence during biopsy by using a handheld vacuum-assisted device initial experience显示文摘 | March DE Coughlin BF Barham RB | | 0，，02： | 1 |
| 17 | Rapid ashy for detecting sulfonamides in tissues of slaughtered animals显示文摘 | Barham R Black W D Claxton J | 2001 | J Food Protection2001，64，10： | 1 |
| 18 | Xen and the Art of Virtualization显示文摘 | Barham P Dragovic B Fraser K | 2003 | ACM SIGOPS Operating Systems Review2003，37，5： | 1 |
| 19 | Identification, course and treatment of depression after admission for a cardiac condition: Rationale and patient characteristic for the identifying depression as acomorbid condition ( IDACC ) project 显示文摘 | CHEOK F SCHRADER G BARHAM D | 2003 | J Am Heat2003，146，： | 1 |
| 20 | Review High-Strength Polyethylene Fibers from Solution and Gel Spinning显示文摘 | Barham P J Keller A | | 0，，20： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员